☰

Joel N. Glasgow - Publications

Affiliations: 
2000 University of Texas Medical Branch, Galveston, TX 
Tree Info Grants Similar researchers PubMed Report error

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Lewis TB, Glasgow JN, Harms AS, Standaert DG, Curiel DT. Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy. Viruses. 6: 3293-310. PMID 25196484 DOI: 10.3390/V6083293  0.448
2013 Kim JW, Glasgow JN, Nakayama M, Ak F, Ugai H, Curiel DT. An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer. Plos One. 8: e55533. PMID 23383334 DOI: 10.1371/Journal.Pone.0055533  0.415
2010 Lewis TB, Glasgow JN, Glandon AM, Curiel DT, Standaert DG. Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy. Plos One. 5. PMID 20862245 DOI: 10.1371/Journal.Pone.0012672  0.427
2010 Murakami M, Ugai H, Wang M, Belousova N, Dent P, Fisher PB, Glasgow JN, Everts M, Curiel DT. An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations. Virology. 407: 196-205. PMID 20828776 DOI: 10.1016/J.Virol.2010.08.010  0.38
2009 Glasgow JN, Mikheeva G, Krasnykh V, Curiel DT. A strategy for adenovirus vector targeting with a secreted single chain antibody. Plos One. 4: e8355. PMID 20027223 DOI: 10.1371/Journal.Pone.0008355  0.43
2009 Thacker EE, Nakayama M, Smith BF, Bird RC, Muminova Z, Strong TV, Timares L, Korokhov N, O'Neill AM, de Gruijl TD, Glasgow JN, Tani K, Curiel DT. A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo. Vaccine. 27: 7116-24. PMID 19786146 DOI: 10.1016/J.Vaccine.2009.09.055  0.376
2008 Preuss MA, Glasgow JN, Everts M, Stoff-Khalili MA, Wu H, Curiel DT. Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors. The Open Gene Therapy Journal. 1: 7-11. PMID 19834585 DOI: 10.2174/1875037000801010007  0.409
2008 San Martín C, Glasgow JN, Borovjagin A, Beatty MS, Kashentseva EA, Curiel DT, Marabini R, Dmitriev IP. Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid. Journal of Molecular Biology. 383: 923-34. PMID 18786542 DOI: 10.1016/J.Jmb.2008.08.054  0.371
2008 Paul CP, Everts M, Glasgow JN, Dent P, Fisher PB, Ulasov IV, Lesniak MS, Stoff-Khalili MA, Roth JC, Preuss MA, Dirven CM, Lamfers ML, Siegal GP, Zhu ZB, Curiel DT. Characterization of infectivity of knob-modified adenoviral vectors in glioma. Cancer Biology & Therapy. 7: 786-93. PMID 18756624 DOI: 10.4161/Cbt.7.5.5421  0.455
2007 Van Houdt WJ, Wu H, Glasgow JN, Lamfers ML, Dirven CM, Gillespie GY, Curiel DT, Haviv YS. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models. Neuro-Oncology. 9: 280-90. PMID 17522331 DOI: 10.1215/15228517-2007-017  0.462
2007 Tsuruta Y, Pereboeva L, Glasgow JN, Rein DT, Kawakami Y, Alvarez RD, Rocconi RP, Siegal GP, Dent P, Fisher PB, Curiel DT. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2777-83. PMID 17473211 DOI: 10.1158/1078-0432.Ccr-06-2706  0.418
2007 Ulasov IV, Tyler MA, Han Y, Glasgow JN, Lesniak MS. Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma. Human Gene Therapy. 18: 118-29. PMID 17328684 DOI: 10.1089/Hum.2006.146  0.349
2007 Perreau M, Mennechet F, Serratrice N, Glasgow JN, Curiel DT, Wodrich H, Kremer EJ. Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy. Journal of Virology. 81: 3272-84. PMID 17229706 DOI: 10.1128/Jvi.01530-06  0.35
2006 Nakayama M, Both GW, Banizs B, Tsuruta Y, Yamamoto S, Kawakami Y, Douglas JT, Tani K, Curiel DT, Glasgow JN. An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution in mice. Virology. 350: 103-15. PMID 16516257 DOI: 10.1016/J.Virol.2006.01.037  0.435
2006 Glasgow JN, Everts M, Curiel DT. Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Therapy. 13: 830-44. PMID 16439993 DOI: 10.1038/Sj.Cgt.7700928  0.449
2006 Le LP, Rivera AA, Glasgow JN, Ternovoi VV, Wu H, Wang M, Smith BF, Siegal GP, Curiel DT. Infectivity enhancement for adenoviral transduction of canine osteosarcoma cells. Gene Therapy. 13: 389-99. PMID 16292351 DOI: 10.1038/Sj.Gt.3302674  0.405
2006 Hedley SJ, Auf der Maur A, Hohn S, Escher D, Barberis A, Glasgow JN, Douglas JT, Korokhov N, Curiel DT. An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery. Gene Therapy. 13: 88-94. PMID 16107860 DOI: 10.1038/Sj.Gt.3302603  0.442
2006 Nakayama M, Glasgow JN, Smith BF, Li J, Korokhov N, Belousova N, Tani K, Curiel DT. 131. Design and Construction of an Adenovirus Vector Containing Fiber Fibritin/Canine CD40L Fibers Directed to Canine CD40-Expressing Cells Molecular Therapy. 13: S53. DOI: 10.1016/J.Ymthe.2006.08.152  0.434
2005 Izumi M, Kawakami Y, Glasgow JN, Belousova N, Everts M, Kim-Park S, Yamamoto S, Wang M, Le LP, Reynolds PN, Curiel DT. In vivo analysis of a genetically modified adenoviral vector targeted to human CD40 using a novel transient transgenic model. The Journal of Gene Medicine. 7: 1517-25. PMID 16170831 DOI: 10.1002/Jgm.806  0.374
2005 Tsuruta Y, Pereboeva L, Glasgow JN, Luongo CL, Komarova S, Kawakami Y, Curiel DT. Reovirus sigma1 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathway. Biochemical and Biophysical Research Communications. 335: 205-14. PMID 16061208 DOI: 10.1016/J.Bbrc.2005.07.054  0.435
2005 Stoff-Khalili MA, Rivera AA, Glasgow JN, Le LP, Stoff A, Everts M, Tsuruta Y, Kawakami Y, Bauerschmitz GJ, Mathis JM, Pereboeva L, Seigal GP, Dall P, Curiel DT. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy. Gene Therapy. 12: 1696-706. PMID 16034451 DOI: 10.1038/Sj.Gt.3302588  0.449
2005 Breidenbach M, Rein DT, Everts M, Glasgow JN, Wang M, Passineau MJ, Alvarez RD, Korokhov N, Curiel DT. Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy. Gene Therapy. 12: 187-93. PMID 15526007 DOI: 10.1038/Sj.Gt.3302404  0.413
2005 Stoff-Khalili MA, Rivera AA, Glasgow JN, Le LP, Stoff A, Everts M, Tsuruta Y, Kawakami Y, Mathis JM, Pereboeva L, Dall P, Curiel DT. 1018. Infectivity Enhancement for Ovarian Cancer and Glioma Via a Novel Human Adenoviral Vector with a Chimeric Fiber Derived from Canine Adenovirus Type 1 Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.565  0.451
2005 Everts M, Kim-Park S, Preuss MA, Passineau MJ, Glasgow JN, Pereboev AV, Mahasreshti PJ, Grizzle WE, Reynolds PN, Curiel DT. 1017. Selective Induction of Tumor-Associated Antigens in Murine Pulmonary Vasculature Using Double-Targeted Adenoviral Vectors Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.564  0.35
2005 Nakayama M, Glasgow JN, Both GW, Palmarini M, Tsuruta Y, Tani K, Douglas JT, Curiel DT. 886. An Adenovirus Vector with a Chimeric Fiber Derived from Ovine Adenovirus for Novel Tropism Discovery Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.429  0.476
2005 Glasgow JN, Kashentseva E, Dmitriev IP, Curiel DT. 873. Adenovirus Polypeptide IIIa as a Novel Locale for Incorporation of Heterologous Peptides Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.416  0.417
2005 Tsuruta Y, Pereboeva L, Glasgow JN, Kawakami Y, Curiel DT. 528. Infectivity Enhancement of a Genetic Fiber Mosaic Adenovirus Vector in Ovarian Cancer Cells Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.068  0.46
2005 Glasgow JN, Korokhov N, Curiel DT. 28. Adenovirus Targeting Via Leucine Zipper Peptide-Mediated Ligand Attachment Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.040  0.456
2004 Glasgow JN, Kremer EJ, Hemminki A, Siegal GP, Douglas JT, Curiel DT. An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism. Virology. 324: 103-16. PMID 15183058 DOI: 10.1016/J.Virol.2004.03.028  0.466
2004 Glasgow JN, Bauerschmitz GJ, Curiel DT, Hemminki A. Transductional and transcriptional targeting of adenovirus for clinical applications. Current Gene Therapy. 4: 1-14. PMID 15032610 DOI: 10.2174/1566523044577997  0.414
2004 Kawakami Y, Danilov SM, Reynolds PN, Grunda JM, Passineau M, Balyasnikova IV, Glasgow JN, Wang M, Zhu Z, Triozzi PL, Aldrich WA, Blackwell JL, Curiel DT. 664. Surface-Expressed Angiotensin-Converting Enzyme as a Novel Approach To Target Adenovirus to Dendritic Cells Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.628  0.386
2004 Glasgow JN, Mhashilkar A, Curiel DT, Korokhov N. 662. Adenovirus Targeting Via Leucine Zipper Peptide Ligand Attachment Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.626  0.458
2004 Tsuruta Y, Pereboeva L, Glasgow JN, Luongo CL, Komarova S, Kawakami Y, Curiel DT. 129. Infectivity enhancement of an adenovirus vector via genetic incorporation of the reovirus spike protein sigma 1 Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.085  0.478
2004 Izumi M, Kawakami Y, Glasgow JN, Belousova N, Curiel DT. 122. Expression of hCD40 in the Pulmonary Endothelium Targeted Via a Fiber-Modified Adenovirus Improves Gene Delivery to the Lung Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.063  0.431
2003 Takayama K, Reynolds PN, Short JJ, Kawakami Y, Adachi Y, Glasgow JN, Rots MG, Krasnykh V, Douglas JT, Curiel DT. A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism. Virology. 309: 282-93. PMID 12758175 DOI: 10.1016/S0042-6822(03)00067-9  0.442
2002 Haviv YS, Takayama K, Glasgow JN, Blackwell JL, Wang M, Lei X, Curiel DT. A model system for the design of armed replicating adenoviruses using p53 as a candidate transgene. Molecular Cancer Therapeutics. 1: 321-8. PMID 12489848  0.339
2001 Glasgow JN, Qiu J, Rassin D, Grafe M, Wood T, Perez-Pol JR. Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain. Neurochemical Research. 26: 647-59. PMID 11519724 DOI: 10.1023/A:1010987220034  0.366
2001 Qiu J, Grafe MR, Schmura SM, Glasgow JN, Kent TA, Rassin DK, Perez-Polo JR. Differential NF-kappa B regulation of bcl-x gene expression in hippocampus and basal forebrain in response to hypoxia. Journal of Neuroscience Research. 64: 223-34. PMID 11319766 DOI: 10.1002/Jnr.1070  0.607
2000 Glasgow J, Perez-Polo R. One path to cell death in the nervous system. Neurochemical Research. 25: 1373-83. PMID 11059808 DOI: 10.1023/A:1007612716591  0.345
2000 Glasgow JN, Wood T, Perez-Polo JR. Identification and characterization of nuclear factor kappaB binding sites in the murine bcl-x promoter. Journal of Neurochemistry. 75: 1377-89. PMID 10987817 DOI: 10.1046/J.1471-4159.2000.0751377.X  0.518
2000 Gu Z, Toliver-Kinsky T, Glasgow J, Werrbach-Perez K, Perez-Polo JR. NGF-mediated alteration of NF-kappaB binding activity after partial immunolesions to rat cholinergic basal forebrain neurons. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 18: 455-68. PMID 10817930 DOI: 10.1016/S0736-5748(00)00004-6  0.483
Show low-probability matches.